Bolt Biotherapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell BOLT and other ETFs, options, and stocks.About BOLT
Bolt Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company developing novel immunotherapies for the treatment of cancer. Its pipeline includes BDC-1001, a HER2-targeting Boltbody Immune-Stimulating Antibody Conjugate (ISAC), BDC-3042, a myeloid-modulating antibody, and multiple Boltbody ISAC collaboration programs.
CEORandall C. Schatzman
CEORandall C. Schatzman
Employees100
Employees100
HeadquartersRedwood City, California
HeadquartersRedwood City, California
Founded2015
Founded2015
Employees100
Employees100
BOLT Key Statistics
Market cap42.32M
Market cap42.32M
Price-Earnings ratio-0.63
Price-Earnings ratio-0.63
Dividend yield—
Dividend yield—
Average volume109.34K
Average volume109.34K
High today$1.20
High today$1.20
Low today$1.10
Low today$1.10
Open price$1.18
Open price$1.18
Volume122.27K
Volume122.27K
52 Week high$2.03
52 Week high$2.03
52 Week low$0.84
52 Week low$0.84
Analyst ratings
83%
of 6 ratingsBuy
83.3%
Hold
16.7%
Sell
0%